Treatment strategies after SSRI failure--good news and bad news

Editorial

David R Rubinow. N Engl J Med. 2006.

. 2006 Mar 23;354(12):1305-7.

doi: 10.1056/NEJMe068029.

No abstract available

Comment in

Depression--augmentation or switch after initial SSRI treatment.
Tebartz van Elst L, Ebert D, Hesslinger B. Tebartz van Elst L, et al. N Engl J Med. 2006 Jun 15;354(24):2611-3; author reply 2611-3. N Engl J Med. 2006. PMID: 16775880 No abstract available.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team. Rush AJ, et al. N Engl J Med. 2006 Mar 23;354(12):1231-42. doi: 10.1056/NEJMoa052963. N Engl J Med. 2006. PMID: 16554525 Clinical Trial.
Medication augmentation after the failure of SSRIs for depression.
Trivedi MH, Fava M, Wisniewski SR, Thase ME, Quitkin F, Warden D, Ritz L, Nierenberg AA, Lebowitz BD, Biggs MM, Luther JF, Shores-Wilson K, Rush AJ; STAR*D Study Team. Trivedi MH, et al. N Engl J Med. 2006 Mar 23;354(12):1243-52. doi: 10.1056/NEJMoa052964. N Engl J Med. 2006. PMID: 16554526 Clinical Trial.